SCHEMBL23450081

SCHEMBL23450081

COC(=O)c1ccc(N)c(NN(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.55
▸ KDM4E B2RXH2 8/20 0.54
▸ ALDH1A1 P00352 5/20 0.54
▸ GAA P10253 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ HSD17B10 Q99714 3/20 0.54
▸ HPGD P15428 3/20 0.54
▸ GLA P06280 1/20 0.54
▸ CASP1 P29466 1/20 0.54
▸ CASP7 P55210 1/20 0.54
▸ ATM Q13315 1/20 0.54
▸ LNPEP Q9UIQ6 7/20 0.53
▸ ERAP2 Q6P179 3/20 0.53
▸ KMT2A Q03164 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA7 P43166 1/20 0.46
▸ XDH P47989 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222734 0.81 KDM4E (0.59) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL24281981 0.80 KDM4E (0.57) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL22009883 0.78 KDM4E (0.50) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL2014323 0.77 LNPEP (0.56) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL25351231 0.77 HDAC1 (0.55) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL192100 0.77 KDM4E (0.72) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL29375113 0.77 KDM4E (0.72) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL24265280 0.76 HDAC1 (0.53) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL23450340 0.76 VCAM1 (0.53) ALDH1A1HPGDKMT2ANPSR1LMNA
Hydrochloric Acid SCHEMBL1223871 0.75 KDM4E (0.70) HDAC1KDM4EALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163455-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2021-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163455-A1 GLP-1 Receptor Agonists and Uses Thereof GLP1R, GIPR, GCGR HDAC1 435/4885KDM4E 1142/4885ALDH1A1 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback